Nuo Therapeutics Inc (NUOTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 1,609 | 2,169 | 2,895 | 4,837 | 1,898 |
| Cost of Goods | 1,160 | 1,600 | 2,382 | 2,825 | 2,086 |
| Gross Profit | 450 | 569 | 513 | 2,012 | -188 |
| Operating Expenses | 6,862 | 28,428 | 5,332 | 6,208 | 4,319 |
| Operating Income | -6,253 | -27,259 | -4,437 | -3,371 | -4,421 |
| Interest Expense | 1,026 | 967 | 913 | 867 | 847 |
| Other Income | -35,041 | 14,402 | 4,484 | 8,350 | 8,130 |
| Pre-tax Income | -42,320 | -13,824 | -865 | 4,112 | 2,862 |
| Income Tax | -104 | 5 | 5 | 5 | 6 |
| Net Income Continuous | -42,216 | -13,829 | -870 | 4,107 | 2,856 |
| Net Income | $-42,216 | $-13,829 | $-870 | $4,107 | $2,856 |
| EPS Basic Total Ops | -0.32 | -0.11 | -0.01 | 0.02 | 0.02 |
| EPS Basic Continuous Ops | -0.34 | -0.11 | -0.01 | 0.03 | 0.03 |
| EPS Diluted Total Ops | -0.32 | -0.11 | -0.01 | 0.02 | 0.02 |
| EPS Diluted Continuous Ops | -0.34 | -0.11 | -0.01 | 0.03 | 0.03 |
| EPS Diluted Before Non-Recurring Items | -9,999.00 | -0.04 | -0.05 | 0.02 | 0.03 |
| EBITDA(a) | $-29,786 | $-3,331 | $-4,629 | $-2,833 | $-8,972 |